CS208661B2 - Method of making the n-/2-phenyl-2-hydroxyethyl/-1,1-dimethyl-3-phenylpropylamin derivatives - Google Patents

Method of making the n-/2-phenyl-2-hydroxyethyl/-1,1-dimethyl-3-phenylpropylamin derivatives Download PDF

Info

Publication number
CS208661B2
CS208661B2 CS794630A CS156480A CS208661B2 CS 208661 B2 CS208661 B2 CS 208661B2 CS 794630 A CS794630 A CS 794630A CS 156480 A CS156480 A CS 156480A CS 208661 B2 CS208661 B2 CS 208661B2
Authority
CS
Czechoslovakia
Prior art keywords
compounds
dimethyl
compound
phenyl
animals
Prior art date
Application number
CS794630A
Other languages
Czech (cs)
English (en)
Inventor
Jack Mills
Klaus K Schmiegel
Richard E Toomey
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CS208661B2 publication Critical patent/CS208661B2/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
CS794630A 1978-07-03 1979-07-02 Method of making the n-/2-phenyl-2-hydroxyethyl/-1,1-dimethyl-3-phenylpropylamin derivatives CS208661B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92166878A 1978-07-03 1978-07-03

Publications (1)

Publication Number Publication Date
CS208661B2 true CS208661B2 (en) 1981-09-15

Family

ID=25445786

Family Applications (2)

Application Number Title Priority Date Filing Date
CS794630A CS208661B2 (en) 1978-07-03 1979-07-02 Method of making the n-/2-phenyl-2-hydroxyethyl/-1,1-dimethyl-3-phenylpropylamin derivatives
CS794630A CS208660B2 (en) 1978-07-03 1979-07-02 Method of making the n-/2-phenyl-2-hydroxyethyl/-1,1-dimethyl-3-phenylpropylamin derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
CS794630A CS208660B2 (en) 1978-07-03 1979-07-02 Method of making the n-/2-phenyl-2-hydroxyethyl/-1,1-dimethyl-3-phenylpropylamin derivatives

Country Status (33)

Country Link
EP (2) EP0047536B1 (el)
JP (1) JPS559100A (el)
AR (2) AR222658A1 (el)
AT (1) AT370408B (el)
AU (1) AU521744B2 (el)
BE (1) BE877392A (el)
BG (3) BG40481A3 (el)
CA (1) CA1120058A (el)
CH (1) CH641759A5 (el)
CS (2) CS208661B2 (el)
DD (1) DD144763A5 (el)
DK (1) DK268579A (el)
EG (1) EG14400A (el)
ES (2) ES482153A1 (el)
FI (1) FI67686C (el)
FR (1) FR2430409A1 (el)
GB (1) GB2028800B (el)
GR (1) GR72546B (el)
HK (1) HK44087A (el)
HU (1) HU179170B (el)
IE (1) IE48436B1 (el)
IL (1) IL57670A (el)
LU (1) LU81456A1 (el)
MX (1) MX6160E (el)
MY (1) MY8500596A (el)
NZ (1) NZ190859A (el)
PH (1) PH15650A (el)
PL (2) PL119783B1 (el)
PT (1) PT69840A (el)
RO (2) RO77731A (el)
SU (2) SU965351A3 (el)
YU (1) YU154879A (el)
ZA (1) ZA793295B (el)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2965655D1 (en) * 1978-06-28 1983-07-21 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
NL8105170A (nl) * 1980-12-10 1982-07-01 Thomae Gmbh Dr K Nieuwe fenylalkylaminen, werkwijze ter bereiding daarvan en de toepassing daarvan als geneesmiddelen.
EP0068669A1 (en) * 1981-06-20 1983-01-05 Beecham Group Plc Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application
CA1219865A (en) * 1982-05-14 1987-03-31 Leo Alig Aziridine phenethanolamine derivatives
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
EP0102213A1 (en) * 1982-08-21 1984-03-07 Beecham Group Plc Ethanolamine derivatives, pharmaceutical compositions containing them, and processes for preparing them
EP0117647B1 (en) * 1983-01-31 1988-08-17 Eli Lilly And Company Improvements in or relating to phenethanolamines
US4849453A (en) * 1983-01-31 1989-07-18 Eli Lilly And Company Growth promotion
US4569801A (en) * 1984-10-15 1986-02-11 Eli Lilly And Company Alkylsulfonamidophenylalkylamines
JPS62155213A (ja) * 1985-12-20 1987-07-10 イ−ライ・リリ−・アンド・カンパニ− 腫瘍細胞崩壊剤
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
US5135955A (en) * 1988-04-25 1992-08-04 Eli Lilly And Company Propanamine derivatives
US5051423A (en) * 1988-07-13 1991-09-24 Schering Ag Derivatized alkanolamines as cardiovascular agents
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5541197A (en) * 1994-04-26 1996-07-30 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
CN1073983C (zh) * 1994-10-31 2001-10-31 中国科学院成都有机化学研究所 一种β－拟肾上腺素兴奋剂型饲料添加剂的合成方法
JP4448902B2 (ja) * 2001-06-08 2010-04-14 株式会社医薬分子設計研究所 スルホンアミド誘導体
TW200740779A (en) 2005-07-22 2007-11-01 Mitsubishi Pharma Corp Intermediate compound for synthesizing pharmaceutical agent and production method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6610530A (el) * 1966-07-27 1968-01-29
BE757005A (fr) * 1969-10-02 1971-04-02 Bristol Myers Co Phenethanolamines substituees et procede pour leur preparation
US3801631A (en) * 1972-02-16 1974-04-02 Mead Johnson & Co 2'-hydroxy-5'-(1-hydroxy-2-(2-methyl-1-phenyl-2-propylamino)ethyl)meth-anesulfonanilide and its salts

Also Published As

Publication number Publication date
JPS559100A (en) 1980-01-22
CS208660B2 (en) 1981-09-15
EP0047536B1 (en) 1984-06-27
FI67686C (fi) 1985-05-10
RO77731A (ro) 1981-11-24
IE791231L (en) 1980-01-03
RO83053A (ro) 1984-02-21
ZA793295B (en) 1981-02-25
PH15650A (en) 1983-03-11
AR222727A1 (es) 1981-06-15
PL216810A1 (el) 1980-07-28
AU4848879A (en) 1980-01-10
GB2028800A (en) 1980-03-12
FR2430409B1 (el) 1981-05-29
ES482153A1 (es) 1980-08-16
MX6160E (es) 1984-11-29
BG40480A3 (en) 1986-12-15
NZ190859A (en) 1984-09-28
PT69840A (en) 1979-07-01
PL123990B1 (en) 1982-12-31
EP0047536A3 (en) 1982-03-24
GB2028800B (en) 1982-11-03
BG40481A3 (en) 1986-12-15
EG14400A (en) 1983-12-31
RO83053B (ro) 1984-02-28
FI792080A (fi) 1980-01-04
ATA463979A (de) 1982-08-15
BE877392A (fr) 1980-01-02
GR72546B (el) 1983-11-17
CH641759A5 (fr) 1984-03-15
MY8500596A (en) 1985-12-31
AR222658A1 (es) 1981-06-15
ES487847A0 (es) 1980-12-16
FI67686B (fi) 1985-01-31
ES8101537A1 (es) 1980-12-16
EP0007206B1 (en) 1983-02-23
SU965351A3 (ru) 1982-10-07
IL57670A0 (en) 1979-10-31
DK268579A (da) 1980-01-04
IL57670A (en) 1982-11-30
FR2430409A1 (fr) 1980-02-01
EP0007206A1 (en) 1980-01-23
PL222867A1 (el) 1981-01-02
BG40482A3 (en) 1986-12-15
DD144763A5 (de) 1980-11-05
IE48436B1 (en) 1985-01-23
LU81456A1 (fr) 1979-10-30
PL119783B1 (en) 1982-01-30
HK44087A (en) 1987-06-12
JPS636058B2 (el) 1988-02-08
EP0047536A2 (en) 1982-03-17
AU521744B2 (en) 1982-04-29
AT370408B (de) 1983-03-25
YU154879A (en) 1983-04-30
HU179170B (en) 1982-08-28
CA1120058A (en) 1982-03-16
SU931102A3 (ru) 1982-05-23

Similar Documents

Publication Publication Date Title
CS208661B2 (en) Method of making the n-/2-phenyl-2-hydroxyethyl/-1,1-dimethyl-3-phenylpropylamin derivatives
US20060252748A1 (en) Use of CDK II inhibitors for birth control
JPH07300417A (ja) 抗うつまたは抗パーキンソン病薬
WO2008061456A1 (fr) Composé folacine-metformine et sa production
RU2043994C1 (ru) Глутатионалкиловые эфиры окисленного типа и способ их получения
CZ20023701A3 (cs) Inhibitory transportu fosfátu
US6881744B2 (en) Carbinoxamine tannate
CH655924A5 (fr) Derives de l'acide 4-phenyl 4-oxo 2-butenoique, leurs sels, leur preparation, medicaments et compositions les renfermant.
JPH05500972A (ja) 抗腫瘍薬剤の製造へのテトラヒドロイソキノリン誘導体の使用
AU698673B2 (en) Heterocyclic chemistry
CS221810B2 (en) Method of making the new isochinoline derivatives with contanets of sulphur
EP0098589A1 (en) Quinazoline derivatives which are active against coccidiosis
JPS60158149A (ja) 炎症抑制作用を有する１，４‐ナフトキノン誘導体
IE49343B1 (en) Preparation of pharmacologically-active piperidyl-indoles
SK284397B6 (sk) Farmaceutický prostriedok
US3463861A (en) Compositions and method of treating mycobacterium tuberculosis with 2,2'-(ethylenediimino)-di-1-butanols
US5945455A (en) Amine and amidine containing compounds as weight reducing agents
CA2264101A1 (en) Preventives/remedies for muscle tissue degenerations
EP0906275B1 (en) New forms of organic salts of n'n-diacetylcystine
HU210154B (en) Process for producing new famotidin-salts and pharmaceutical compositions of gastro-acid-secretion-inhibiting and gastro-citoprotective activity, containing them
US4100287A (en) Pyrimidine derivative
JPS62108863A (ja) ２−ピリジル酢酸誘導体、その製法およびそれを含む医薬
US4419367A (en) Stimulant
US7001886B2 (en) Hot melt method for preparing diphenhydramine tannate
KR800000262B1 (ko) 3-아미노-2-하이드록시프로판의 디치환 페놀 에텔 유도체의 제조방법